1. Testicular Metastasis of Prostatic Adenocarcinoma after Ablatherm® Treatment
- Author
-
Lionel D'Hondt, Marcelo Di Gregorio, Marie-Cécile Nollevaux, and Francis Lorge
- Subjects
Prostate adenocarcinoma ,Gynecology ,endocrine system ,medicine.medical_specialty ,Pathology ,endocrine system diseases ,urogenital system ,business.industry ,Prostatic adenocarcinoma ,030232 urology & nephrology ,Testicular metastasis ,urologic and male genital diseases ,medicine.disease ,Left Testis ,Metastasis ,03 medical and health sciences ,0302 clinical medicine ,medicine.anatomical_structure ,Prostate ,030220 oncology & carcinogenesis ,medicine ,Adenocarcinoma ,Immunohistochemistry ,business - Abstract
Testicular metastases are rare in prostatic adenocarcinomas. The discovery is often fortuitous, and they are diagnosed with a histological examination. Metastasis is often confused with a primitive testicular tumor. We describe an 86-year-old patient with metastatic prostate adenocarcinoma that affected the left testis. The metastasis was discovered after Ablatherm® treatment. A prostatic origin must be suspected in a patient over 50 years old with testicular metastasis. This study highlights the importance of clinicopathological investigation and immunohistochemistry in determining the etiopathogenesis of testicular masses.
- Published
- 2017
- Full Text
- View/download PDF